266 related articles for article (PubMed ID: 33678480)
1. Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
Backes FJ; Felix AS; Plante M; Grégoire J; Sullivan SA; Rossi EC; Tanner EJ; Stewart KI; Soliman PT; Holloway RW; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 May; 161(2):347-352. PubMed ID: 33678480
[TBL] [Abstract][Full Text] [Related]
2. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study.
Ghoniem K; Larish AM; Dinoi G; Zhou XC; Alhilli M; Wallace S; Wohlmuth C; Baiocchi G; Tokgozoglu N; Raspagliesi F; Buda A; Zanagnolo V; Zapardiel I; Jagasia N; Giuntoli R; Glickman A; Peiretti M; Lanner M; Chacon E; Di Guilmi J; Pereira A; Laas E; Fishman A; Nitschmann CC; Parker S; Joehlin-Price A; Lees B; Covens A; De Brot L; Taskiran C; Bogani G; Paniga C; Multinu F; Hernandez-Gutierrez A; Weaver AL; McGree ME; Mariani A
Gynecol Oncol; 2021 Sep; 162(3):590-598. PubMed ID: 34274133
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
[TBL] [Abstract][Full Text] [Related]
8. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
[TBL] [Abstract][Full Text] [Related]
9. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
[TBL] [Abstract][Full Text] [Related]
10. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN
Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730
[TBL] [Abstract][Full Text] [Related]
12. Retrospective detection of isolated tumor cells by immunohistochemistry in sentinel lymph node biopsy performed for endometrial carcinoma: is there clinical significance?
Goebel EA; St Laurent JD; Nucci MR; Feltmate CM
Int J Gynecol Cancer; 2020 Mar; 30(3):291-298. PubMed ID: 31818860
[TBL] [Abstract][Full Text] [Related]
13. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
15. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
17. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
[TBL] [Abstract][Full Text] [Related]
18. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
19. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
[TBL] [Abstract][Full Text] [Related]
20. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
